Reply to: "Metabolomics to discriminate between acute decompensation and acute-on-chronic liver failure in cirrhosis"

J Hepatol. 2020 Sep;73(3):732-734. doi: 10.1016/j.jhep.2020.05.021. Epub 2020 Jul 9.

Authors

Richard Moreau¹, Ferran Aguilar², Vicente Arroyo²

Affiliations

¹ EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain; Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI); UMRS1149, Université de Paris, France; Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France. Electronic address: richard.moreau@inserm.fr.
² EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain.

PMID: 32653223
DOI: 10.1016/j.jhep.2020.05.021

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Acute-On-Chronic Liver Failure* / diagnosis
Acute-On-Chronic Liver Failure* / etiology
Humans
Inflammation
Liver Cirrhosis / complications
Liver Cirrhosis / diagnosis
Metabolomics
Mitochondria